 |
 |
 |
 |
 |
 |
 |
|
|
|
|||||||||
|
|||||||||||
Research Articles |
OBJECTIVE: To report a case of symptomatic cardiomyopathy induced during treatment with clozapine, an antipsychotic of the dibenzodiazepine class. CASE SUMMARY: A patient with a long psychiatric history significant for schizophrenia and no prior cardiac history developed dyspnea, malaise, and edema with a low ventricular ejection fraction during clozapine therapy. DISCUSSION: The literature concerning cardiorespiratory complications with clozapine therapy is reviewed. CONCLUSIONS: Cardiorespiratory complications associated with clozapine use are rare. Caution may be warranted in patients treated with other medications, such as benzodiazepines, and in patients with underlying cardiac disease.
This article has been cited by other articles:
|
|
 |
|
  C. A. Pastor and M. Mehta Masked Clozapine-induced Cardiomyopathy J Am Board Fam Med, January 1, 2008; 21(1): 70 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Amabile and A. P. Spencer Keeping Your Patient With Heart Failure Safe: A Review of Potentially Dangerous Medications Arch Intern Med, April 12, 2004; 164(7): 709 - 720. [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. D. Phan and S. F. Taylor Clozapine-Associated Cardiomyopathy Psychosomatics, June 1, 2002; 43(3): 248 - 248. [Full Text] [PDF]
|
|
 |
 |
 |
 |
 |
 |
 |
